A blood screening test for Alzheimer's disease-Reference-Cited by-同舟云学术

A blood screening test for Alzheimer's disease

Published:2016-01 Issue:1 Volume:3 Page:83-90
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Author:

O'Bryant Sid E.¹,Edwards Melissa²,Johnson Leigh¹,Hall James¹,Villarreal Alcibiades E.³⁴,Britton Gabrielle B.³,Quiceno Mary⁵,Cullum C. Munro⁵,Graff‐Radford Neill R.⁶

Affiliation:

1. Institute for Healthy Aging, University of North Texas Health Science CenterFort WorthTXUSA

2. Department of PsychologyUniversity of North TexasDentonTXUSA

3. Centro de Neurociencias y Unidad de Investigación ClínicaInstituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP)Ciudad del SaberPanamáPanamá

4. Department of BiotechnologyAcharya Nagarjuna UniversityGunturIndia

5. Department of Neurology and NeurotherapeuticsUniversity of Texas Southwestern Medical CenterDallasTXUSA

6. Department of NeurologyMayo ClinicJacksonvilleFLUSA

Funder

National Institute on Aging

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.dadm.2016.06.004

Reference42 articles.

1. 2008 Alzheimer's disease facts and figures

2. 2013 Alzheimer's Disease Facts and Figures;Alzheimer's Association;Alzheimers Dement,2013

3. Monetary Costs of Dementia in the United States

4. The Gerontological Society of America.The Gerontological Society of America Workgroup on Cognitive Impairment Detection and Earlier Diagnosis: Report and Recommendations.2015

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidities Incorporated to Improve Prediction for Prevalent Mild Cognitive Impairment and Alzheimer’s Disease in the HABS-HD Study;Journal of Alzheimer's Disease;2023-12-06

2. Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease;Alzheimer's & Dementia;2023-11-06

3. Precision Medicine for Preventing Alzheimer’s Disease: Analysis of the ADAPT Study;Journal of Alzheimer's Disease;2023-10-10

4. Blood‐based biomarkers in Alzheimer's disease: Future directions for implementation;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2023-10

5. Digital phenotyping: An equal opportunity approach to reducing disparities in Alzheimer's disease and related dementia research;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2023-10